Recently, LPA was elucidated to stimulate the epithelial-to-mesenchymal switch in ovarian cancer cells via downregulation of SIRT1, an established inactivator of ZEB1 and suppressor of EMT [93]. The gene discussed is ZEB1; the disease is ovarian cancer.